Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
KTTAW | US
0
0%
Healthcare
Biotechnology
30/06/2024
05/06/2026
0.00
0.01
0.01
0.00
Low Market Beta (-0.4 to 0.8)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
381.0%1 month
190.5%3 months
1045.2%6 months
665.9%-
-
-
-
-
-
-
-
-16.27M
-
-
-
-
-
-
-63.25
-
-
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.01
Range1M
0.01
Range3M
0.01
Rel. volume
2.11
Price X volume
232.06
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| CURE Pharmaceutical Holding Corp | CURR | Drug Manufacturers-Specialty & Generic | 3.18 | 0 | -9.40% | n/a | |
| Biofrontera Inc. Warrants | BFRIW | Drug Manufacturers-Specialty & Generic | 0.0226 | 0 | n/a | 13.20% | |
| ICUCW | ICUCW | Biotechnology | 0.0216 | 0 | -1.37% | n/a | -45.50% |
| Humacyte Inc | HUMAW | Biotechnology | 0.054 | 0 | -8.32% | n/a | -63.37% |
| EyeGate Pharmaceuticals Inc | EYEG | Biotechnology | 35.07 | 0 | -0.54% | n/a | |
| CELUW | CELUW | Biotechnology | 0.0049 | 0 | -18.33% | n/a | 127.38% |
| Sunshine Biopharma Inc. Warrant | SBFMW | Drug Manufacturers-Specialty & Generic | 0.0396 | 0 | -12.78% | n/a | 2.46% |
| XOMA Corporation Depositary Shares Rep Series B 8.375% Cumulative Preferred Stock | XOMAO | Biotechnology | 25.3501 | 0 | -0.04% | 25.57 | 121.93% |
| SABSW | SABSW | Biotechnology | 0.0124 | 0 | -12.68% | 0.17 | 11.58% |
| Revolution Medicines Inc. Warrant | RVMDW | Biotechnology | 5.44 | 0 | -14.33% | n/a | 5.40% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
No data | |||||||
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | - | 0.53 | - |
| Ent. to Revenue | - | 3,967.00 | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | - | 15.55 | - |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 1,045.24 | 72.80 | Riskier |
| Debt to Equity | - | -1.23 | - |
| Debt to Assets | - | 0.25 | - |
| Market Cap | - | 3.66B | - |